BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 2787454)

  • 41. Regulation of IgA differentiation in CH12LX B cells by lymphokines. IL-4 induces membrane IgM-positive CH12LX cells to express membrane IgA and IL-5 induces membrane IgA-positive CH12LX cells to secrete IgA.
    Kunimoto DY; Harriman GR; Strober W
    J Immunol; 1988 Aug; 141(3):713-20. PubMed ID: 2456329
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Influence of recombinant IL-4, IFN-alpha, and IFN-gamma on the production of human IgE-binding factor (soluble CD23).
    Delespesse G; Sarfati M; Peleman R
    J Immunol; 1989 Jan; 142(1):134-8. PubMed ID: 2521231
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A T-helper cell x Molt4 human hybridoma constitutively producing B-cell stimulatory and inhibitory factors.
    Rosén A; Uggla C; Szigeti R; Kallin B; Lindqvist C; Zeuthen J
    Lymphokine Res; 1986; 5(3):185-204. PubMed ID: 2943947
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Production of B cell-stimulating factors by B cells in patients with systemic lupus erythematosus.
    Tanaka Y; Saito K; Shirakawa F; Ota T; Suzuki H; Eto S; Yamashita U
    J Immunol; 1988 Nov; 141(9):3043-9. PubMed ID: 3262675
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synergy of B cell growth factor and interleukin 2 in the proliferation of activated human B cells.
    Romagnani S; Giudizi GM; Maggi E; Almerigogna F; Biagiotti R; Del Prete G; Mazzetti M; Alessi A; Vercelli D; Ricci M
    Eur J Immunol; 1985 Dec; 15(12):1158-64. PubMed ID: 3936718
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Costimulatory signals are required for optimal proliferation of human natural killer cells.
    Robertson MJ; Manley TJ; Donahue C; Levine H; Ritz J
    J Immunol; 1993 Mar; 150(5):1705-14. PubMed ID: 7679691
    [TBL] [Abstract][Full Text] [Related]  

  • 47. B cell maturation in chronic lymphocytic leukemia. III. Effect of recombinant cytokines on leukemic B cell proliferation.
    Nerl C; Janssen O; Kabelitz D
    Leukemia; 1988 Dec; 2(12 Suppl):50S-56S. PubMed ID: 3059076
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Recombinant human interleukin 5 is an eosinophil differentiation factor but has no activity in standard human B cell growth factor assays.
    Clutterbuck E; Shields JG; Gordon J; Smith SH; Boyd A; Callard RE; Campbell HD; Young IG; Sanderson CJ
    Eur J Immunol; 1987 Dec; 17(12):1743-50. PubMed ID: 3500861
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Expression of IL-1 receptors on human peripheral B cells.
    Tanaka Y; Shirakawa F; Oda S; Eto S; Yamashita U
    J Immunol; 1989 Jan; 142(1):167-72. PubMed ID: 2521232
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Proliferative response of highly purified B chronic lymphocytic leukemia cells in serum free culture to interleukin-2 and tumor necrosis factors alpha and beta.
    Moberts R; Hoogerbrugge H; van Agthoven T; Löwenberg B; Touw I
    Leuk Res; 1989; 13(11):973-80. PubMed ID: 2481793
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Interleukin-15 + thioredoxin induce DNA synthesis in B-chronic lymphocytic leukemia cells but not in normal B cells.
    Söderberg O; Christiansen I; Nilsson G; Carlsson M; Nilsson K
    Leukemia; 1997 Aug; 11(8):1298-304. PubMed ID: 9264384
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Responsiveness of chronic lymphocytic leukemia B cells activated via surface Igs or CD40 to B-cell tropic factors.
    Fluckiger AC; Rossi JF; Bussel A; Bryon P; Banchereau J; Defrance T
    Blood; 1992 Dec; 80(12):3173-81. PubMed ID: 1281692
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Structure/function analyses of IL-2 binding proteins on human B cell precursor acute lymphoblastic leukemias.
    Wörmann B; Anderson JM; Ling ZD; LeBien TW
    Leukemia; 1987 Sep; 1(9):660-6. PubMed ID: 3118114
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Interleukin-15 promotes the growth of leukemic cells of patients with B-cell chronic lymphoproliferative disorders.
    Trentin L; Cerutti A; Zambello R; Sancretta R; Tassinari C; Facco M; Adami F; Rodeghiero F; Agostini C; Semenzato G
    Blood; 1996 Apr; 87(8):3327-35. PubMed ID: 8605349
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Proliferation of human CD4+45R+ and CD4+45R- T helper cells is promoted by both IL-2 and IL-4 while interferon-gamma production is restricted to IL-2 activated CD4+45R- T cells.
    Dohlsten M; Hedlund G; Fischer H; Sjögren HO; Carlsson R
    Immunol Lett; 1989 Jan; 20(1):29-34. PubMed ID: 2523864
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In vitro effects of recombinant interleukin 7 on growth and differentiation of bone marrow pro-B- and pro-T-lymphocyte clones and fetal thymocyte clones.
    Takeda S; Gillis S; Palacios R
    Proc Natl Acad Sci U S A; 1989 Mar; 86(5):1634-8. PubMed ID: 2784210
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Establishment of a human B cell line that proliferates in response to B cell growth factor.
    Abe H; Rossio JL; Ruscetti FW; Matsushima K; Oppenheim JJ
    J Immunol Methods; 1986 Jun; 90(1):111-23. PubMed ID: 2423613
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Synergistic action of interleukin-2 and Steel factor (SLF) on a human T lymphoblastoid cell line.
    Kees UR; Ashman LK
    Leukemia; 1995 Jun; 9(6):1046-50. PubMed ID: 7541097
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Activity of a partially purified human BCGF on murine assays for B-cell stimulatory factors. I. BCGF II-like activity of human BCGF.
    Ennist DL; Greenblatt D; Coffman R; Sharma S; Maizel A; Howard M
    Cell Immunol; 1987 Nov; 110(1):77-94. PubMed ID: 3499989
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Malignant chronic lymphocytic leukemia B cells express interleukin 2 receptors but fail to respond to interleukin 2's proliferative signal.
    Perri RT; Kay NE
    Leukemia; 1987 Feb; 1(2):127-30. PubMed ID: 3118104
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.